Bringing Artificial Intelligence to Biopharma

April 1, 2022 PAO-04-22-R250-07

At another stop on Pharma's Almanac's the Road to 50 States campaign, Mike Fero, Founder and CEO of TeselaGen Biotechnology, talks to Nigel about the similarities between physics and biology and the informatic platforms TeselaGen offers to biotech companies.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

TeselaGen Biotechnology

TeselaGen is deploying the first solution that incorporates state of the art AI-enabled information technology for biotechnology as a secure enterprise operating system. We make the development of bio-based products faster and easier. We provide a highly secure enterprise quality operating system that our customers can use right away, instead of spending millions to develop it themselves.

Q: